SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
白匪
Lv3
210 积分
2021-08-26 加入
最近求助
最近应助
互助留言
Concurrent olaparib and radiotherapy in elderly patients with newly diagnosed glioblastoma: the phase I dose escalation PARADIGM trial
28天前
已完结
Concurrent Olaparib and Radiotherapy in Patients With Triple-Negative Breast Cancer
1个月前
已完结
Uses of GFR and Albuminuria Level in Acute and Chronic Kidney Disease
1个月前
已完结
Toxicity and response criteria of the Eastern Cooperative Oncology Group
1个月前
已完结
Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial
2个月前
已完结
Randomized Study on Dose Escalation in Definitive Chemoradiation for Patients With Locally Advanced Esophageal Cancer (ARTDECO Study)
4个月前
已完结
Neoadjuvant Chemoradiotherapy Versus Chemotherapy for the Treatment of Locally Advanced Esophageal Adenocarcinoma in the European Multicenter ENSURE Study
4个月前
已完结
The feasibility of dose escalation using intensity-modulated radiotherapy (IMRT) and intensity-modulated proton therapy (IMPT) with FDG PET/CT guided in esophageal cancer
4个月前
已关闭
Association of 3D-CRT and IMRT accelerated hyperfractionated radiotherapy with local control rate and 5-year survival in esophageal squamous cell carcinoma patients
4个月前
已关闭
Preclinical safety profile of RC88-ADC:a novel mesothelin-targeted antibody conjugated with Monomethyl auristatin E
4个月前
已完结
没有进行任何应助
感谢
1个月前
感谢
1个月前
感谢
2个月前
感谢
4个月前
找到 了【积分已退回】
4个月前
找到了【积分已退回】
4个月前
感谢
4个月前
感谢
4个月前
感谢
5个月前
太强了!!!
6个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论